The FDA approved Empliciti to be used in combination with two other FDA-approved treatments, dexamethasone and Revlimid. "FDA Approves New Blood-Cancer Drug Empliciti," published at 11:38 a.m. ET, and an update, incorrectly said Darzalex was used in this drug cocktail.

 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

November 30, 2015 12:41 ET (17:41 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bristol Myers Squibb Charts.